Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
Intravenous levodopa or lisuride infusions can successfully reduce daily motor fluctuations in Parkinson's disease, which indicates adequate striatal dopaminergic mechanisms even in severe cases. In 3 patients who received continuous subcutaneous administration of lisuride, by means of a portable mini-infusion pump, in addition to oral levodopa plus decarboxylase inhibitor, mobility improved considerably and "off" periods were reduced or abolished. This response was maintained for 4 to 7 months without toxic side-effects, but increased dyskinetic movements were observed. All 3 patients were discharged and have been able to live independently during the months on treatment. These results suggest that continuous dopaminergic stimulation with the use of a portable delivery system can be a practical therapeutic tool in parkinsonian patients with complicated motor fluctuations.
Obeso
J A
JA
Luquin
M R
MR
Martínez-Lage
J M
JM
D004873:Ergolines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000295:instrumentation; D007279:Injections, Subcutaneous / Q000295:instrumentation; D008090:Lisuride / Q000008:administration & dosage*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D004873:Ergolines; D008090:Lisuride